GREEN CROSS WellBeing Corporation (KOSDAQ:234690)
9,320.00
-270.00 (-2.82%)
At close: Feb 13, 2026
GREEN CROSS WellBeing Market Cap
GREEN CROSS WellBeing has a market cap or net worth of 165.38 billion as of February 13, 2026. Its market cap has increased by 2.72% in one year.
Market Cap
165.38B
Enterprise Value
230.78B
Revenue
151.06B
Ranking
n/a
PE Ratio
18.10
Stock Price
9,320.00
Market Cap Chart
Since October 14, 2019, GREEN CROSS WellBeing's market cap has decreased from 221.90B to 165.38B, a decrease of -25.47%. That is a compound annual growth rate of -4.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 165.38B | 1.97% |
| Dec 30, 2025 | 162.19B | -9.18% |
| Dec 30, 2024 | 178.59B | 23.74% |
| Dec 28, 2023 | 144.33B | -1.22% |
| Dec 29, 2022 | 146.10B | -18.92% |
| Dec 30, 2021 | 180.19B | -27.50% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Vivozon Pharmaceutical | 204.39B |
| Organoidsciences | 202.51B |
| High Tech Pharm | 160.99B |
| Kyung Dong Pharmaceutical | 153.57B |
| DongKoo Bio & Pharma | 146.84B |
| BL Pharmtech | 144.87B |
| PHARMARESEARCH BIO | 144.86B |
| OPTUS Pharmaceutical | 141.17B |